PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:16 AM ET

Sponsor Check › Person

BC
No photo found yet (own website and image search run after this page is viewed)

Bihua Chen

Named as an officer, director or promoter on SEC Form D filings · CA, MA, KY, TX, NY · May 15, 2013 → Jun 25, 2026

30deals (issuers)
$3.77Breported sold
1,229investors
78Form D filings
2013–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:16 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Bihua Chen is listed as an executive officer, director, and promoter on 78 SEC Form D filings by 30 issuers between May 2013 and Jun 2026. Largest by amount reported sold: Cormorant Global Healthcare Fund, LP (Boston, MA — pooled investment fund — 2013–2026; $637M reported sold to 118 investors), Cormorant Global Healthcare Offshore Fund, Ltd. (Boston, MA — pooled investment fund — 2013–2026; $589.2M reported sold to 52 investors), Cormorant Private Healthcare Fund V LP (Boston, MA — pooled investment fund — 2023–2024; $318M reported sold to 56 investors), Cormorant Private Healthcare Fund IV LP (Boston, MA — pooled investment fund — 2021; $252.7M reported sold to 34 investors), Cormorant Private Healthcare Offshore Fund III LP (Boston, MA — pooled investment fund — 2020–2021; $213.7M reported sold to 38 investors) and 25 more (all listed below).

What this means That is a lot of deals — 30 separate companies raised money with this person listed as executive officer, director, and promoter, over about 13 years. Across those companies the filings report $3.77B sold in total.

Listed alongside Cormorant Asset Management, LLC (45 shared filings, management entity), Jay Scollins (23 shared filings), Cormorant Global Healthcare GP, LLC (14 shared filings, management entity), Amr Salahieh (13 shared filings), Caleb Tripp (12 shared filings) and 103 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Bihua. Each name links to their own page.

The issuers belong to 4 sponsor groups: Cormorant (14 issuers, $2.83B reported sold, 2013–2026), Supira (4 issuers, $219.8M reported sold, 2017–2025), Tp Therapeutics (2 issuers, $98M reported sold, 2014–2018) and Apellis (3 issuers, $24.9M reported sold, 2010–2025).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared the newest 50 of 78 public filings for Bihua Chen and found 12 differences, 3 worth asking the sponsor about: 5 regulator actions name the subject or team members; Bihua Chen appears on 5 deals that stopped filing before reaching their target; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Bihua Chen has not run yet — it is joining a line of 50,436 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:16 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Bihua Chen..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:16 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

12 differences found between the filings for Bihua Chen — 3 worth asking about (compared the newest 50 of 78 filings on Oct 24, 2026; older filings not covered)

Worth asking · Jun 12, 2002 – Jan 19, 2005

5 regulator actions name the subject or team members

Regulator action naming a team member: Samuel D. Waksal and Jack Waksal, Defendants, and Patti Waksal, Relief Defendant (Jan 19, 2005) · Regulator action naming a team member: Taglich Brothers, Inc. and Richard C. Oh (Sep 15, 2004) · Regulator action naming a team member: Samuel D. Waksal and Jack Waksal; Relief Defendant Patti Waksal (Oct 10, 2003) · Regulator action naming a team member: Samuel D. Waksal (Mar 11, 2003) · Regulator action naming a team member: Samuel D. Waksal (Jun 12, 2002)

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

Samuel D. Waksal and Jack Waksal, Defendants, and Patti Waksal, Relief Defendant ↗Samuel D Waksal — PartnerFacts page ↗Taglich Brothers, Inc. and Richard C. Oh ↗Michael N. Taglich — PartnerFacts page ↗
Sources
Note · May 4, 2012 – Aug 17, 2012

Bankruptcy case: Christopher Shen and Yihsuan Ho — filed May 4, 2012

United States Bankruptcy Court, C.D. California docket "Christopher Shen and Yihsuan Ho" filed May 4, 2012, closed Aug 17, 2012. Christopher Shen (listed on the same filings) is listed as Debtor ("Christopher Shen and Yihsuan Ho"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, C.D. California ↗Christopher Shen — PartnerFacts page ↗
Sources
Worth asking · Jun 16, 2021 – Aug 8, 2024

Bihua Chen appears on 5 deals that stopped filing before reaching their target

Cormorant Private Healthcare Offshore Fund V LP (last filing Aug 8, 2024; $119,000,000 sold of $400,000,000); BiVACOR Inc. (last filing Aug 6, 2024; $15,000,000 sold of $36,000,000); Cormorant Private Healthcare Offshore Fund IV LP (last filing Aug 3, 2021; $69,200,000 sold of $400,000,000); Cormorant Private Healthcare Fund III LP (last filing Jun 16, 2021; $206,263,000 sold of $500,000,000); Cormorant Private Healthcare Offshore Fund III LP (last filing Jun 16, 2021; $213,650,000 sold of $500,000,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Cormorant Private Healthcare Offshore Fund V LP — PartnerFacts page ↗BiVACOR Inc. — PartnerFacts page ↗Cormorant Private Healthcare Offshore Fund IV LP — PartnerFacts page ↗Cormorant Private Healthcare Fund III LP — PartnerFacts page ↗
Sources
Worth asking · Jul 29, 2022 – Dec 3, 2025

6 Form Ds were filed more than 15 days after the first sale

Form D filed 349 days after the first sale — Graviton BioScience Corp · Form D filed 21 days after the first sale — Akura Medical, Inc. · Form D filed 25 days after the first sale — Tioga Cardiovascular, Inc. · Form D filed 21 days after the first sale — Chroma Medicine, Inc. · Form D filed 18 days after the first sale — BiVACOR Inc. · and 1 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Dec 4, 2023 ↗Graviton BioScience Corp — PartnerFacts page ↗Form D · Dec 3, 2025 ↗Akura Medical, Inc. — PartnerFacts page ↗
Sources
Note · May 19, 2020 – Aug 6, 2024

17 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — BiVACOR Inc. (latest filing Aug 6, 2024) · No amendment in the last 12 months on an offering that may still be open — Adona Medical, Inc. (latest filing Jul 11, 2024) · No amendment in the last 12 months on an offering that may still be open — BlossomHill Therapeutics, Inc. (latest filing Jan 2, 2024) · No amendment in the last 12 months on an offering that may still be open — Graviton BioScience Corp (latest filing Dec 4, 2023) · No amendment in the last 12 months on an offering that may still be open — Supira Medical, Inc. (latest filing Dec 1, 2023) · and 12 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Aug 6, 2024 ↗BiVACOR Inc. — PartnerFacts page ↗Form D · Jul 11, 2024 ↗Adona Medical, Inc. — PartnerFacts page ↗
Sources
Note · Feb 17, 2021 – Mar 14, 2022

Bihua Chen's role changed at Cormorant Global Healthcare Offshore Fund, Ltd.: executive officer, director → executive officer

The Feb 17, 2021 filing lists Bihua Chen as executive officer, director; the Mar 14, 2022 Form D/A lists executive officer.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D/A · Feb 17, 2021 ↗Form D/A · Mar 14, 2022 ↗Bihua Chen — PartnerFacts page ↗Cormorant Global Healthcare Offshore Fund, Ltd. — PartnerFacts page ↗
Sources
Note · Jul 14, 2020 – Jun 25, 2026

6 offerings changed their target amount between filings

Offering amount lowered between filings — Cormorant Private Healthcare Offshore Fund VI, LP · Offering amount lowered between filings — Cormorant Private Healthcare Fund VI, LP · Offering amount lowered between filings — Cormorant Private Healthcare Offshore Fund V LP · Offering amount lowered between filings — Cormorant Private Healthcare Fund V LP · Offering amount lowered between filings — Cormorant Private Healthcare Offshore Fund III LP · and 1 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Nov 25, 2025 ↗Form D/A (later) · Jun 25, 2026 ↗Cormorant Private Healthcare Offshore Fund VI, LP — PartnerFacts page ↗Form D (earlier) · Nov 25, 2025 ↗
Sources
Note · Mar 11, 2020 – Mar 10, 2022

Industry group changed between filings — Supira Medical, Inc.

"Other" (Mar 11, 2020); then "Other Health Care" (Mar 10, 2022 to Apr 3, 2025).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Mar 11, 2020 ↗Form D · Mar 10, 2022 ↗Supira Medical, Inc. — PartnerFacts page ↗
Sources
Note · Jun 3, 2024

Same name, different state: "Bihua Chen" (PA) is a separate record

This page covers filings where the address state is CA or MA or KY or TX or NY. A separate record, "Bihua Chen" with address state PA, is listed on 1 filing — most recently by Interius BioTherapeutics, Inc. (Jun 3, 2024). Both records have filings in the same period (Jun 3, 2024).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Bihua Chen (PA) — PartnerFacts page ↗Form D · Jun 3, 2024 ↗Interius BioTherapeutics, Inc. — PartnerFacts page ↗Bihua Chen (CA,MA,KY,TX,NY) — this page ↗
Sources
Note · Apr 5, 2023

Same name, different state: "Bihua Chen" (NJ) is a separate record

This page covers filings where the address state is CA or MA or KY or TX or NY. A separate record, "Bihua Chen" with address state NJ, is listed on 1 filing — most recently by Tiger Biotherapeutics Inc. (Apr 5, 2023). Both records have filings in the same period (Apr 5, 2023).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Bihua Chen (NJ) — PartnerFacts page ↗Form D · Apr 5, 2023 ↗Tiger Biotherapeutics Inc. — PartnerFacts page ↗Bihua Chen (CA,MA,KY,TX,NY) — this page ↗
Sources
Note · Feb 21, 2023 – Aug 6, 2024

Address moved from Houston, TX to Huntington Beach, CA — BiVACOR Inc.

The people listed on the Feb 21, 2023 filing give Houston, TX; on the Aug 6, 2024 filing they give Huntington Beach, CA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Feb 21, 2023 ↗Form D · Aug 6, 2024 ↗BiVACOR Inc. — PartnerFacts page ↗
Sources
Note · May 15, 2013 – Jun 25, 2026

Bihua Chen is listed with 4 different address states: MA, CA, TX, NY

MA on 47 filings (May 15, 2013 to Jun 25, 2026); CA on 16 filings (Mar 11, 2020 to Dec 10, 2025); TX on 1 filing (Feb 21, 2023); NY on 1 filing (Feb 14, 2024).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · May 15, 2013 ↗Form D · Mar 11, 2020 ↗Form D · Feb 21, 2023 ↗Form D · Feb 14, 2024 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. We compared the newest 50 of 78 filings (work cap); older filings are not covered here. As of Oct 24, 2026.

5. Money to insiders

2 of 46 offerings report sales commissions totalling $619,499; 0 report finder's fees; 1 reports proceeds to related persons totalling $1,200,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jun 25, 2026 D/A
Cormorant Private Healthcare Fund VI, LP
File 021-565060
$0$0$0None listed on this filingEDGAR ↗
Jun 25, 2026 D/A
Cormorant Private Healthcare Offshore Fund VI, LP
File 021-565061
$0$0$0None listed on this filingEDGAR ↗
Mar 3, 2026 D/A
Cormorant Global Healthcare Fund, LP
File 021-196564
$0$0$0
Certain persons named in Item 3 or affiliate(s) thereof may receive payments deemed to be made from the proceeds of the offering, including management fees. The amount of such payments cannot be estimated at this time.
None listed on this filingEDGAR ↗
Mar 3, 2026 D/A
Cormorant Global Healthcare Offshore Fund, Ltd.
File 021-196566
$0$0$0
Certain persons named in Item 3 or affiliate(s) thereof may receive payments deemed to be made from the proceeds of the offering, including management fees. The amount of such payments cannot be estimated at this time.
None listed on this filingEDGAR ↗
Dec 10, 2025 D
BlossomHill Therapeutics, Inc.
File 021-566357
$0$0$0None listed on this filingEDGAR ↗
Dec 3, 2025 D
Akura Medical, Inc.
File 021-565520
$0$0$0None listed on this filingEDGAR ↗
Sep 16, 2025 D
Tioga Cardiovascular, Inc.
File 021-557658
$0$0$0None listed on this filingEDGAR ↗
Apr 3, 2025 D
Supira Medical, Inc.
File 021-542919
$0$0$0None listed on this filingEDGAR ↗
Aug 8, 2024 D/A
Cormorant Private Healthcare Fund V LP
File 021-489172
$0$0$0None listed on this filingEDGAR ↗
Aug 8, 2024 D/A
Cormorant Private Healthcare Offshore Fund V LP
File 021-489177
$0$0$0None listed on this filingEDGAR ↗
Aug 6, 2024 D
BiVACOR Inc.
File 021-520674
$0$0$0None listed on this filingEDGAR ↗
Jul 11, 2024 D
Adona Medical, Inc.
File 021-518469
$0$0$0None listed on this filingEDGAR ↗
Feb 14, 2024 D
Graviton BioScience Corp
File 021-505280
$0$0$0None listed on this filingEDGAR ↗
Jan 2, 2024 D
BlossomHill Therapeutics, Inc.
File 021-501240
$0$0$0 (est.)None listed on this filingEDGAR ↗
Dec 4, 2023 D
Graviton BioScience Corp
File 021-498756
$0$0$0None listed on this filingEDGAR ↗
Dec 4, 2023 D
Graviton BioScience Corp
File 021-498757
$0$0$0None listed on this filingEDGAR ↗
Dec 1, 2023 D
Supira Medical, Inc.
File 021-498646
$0$0$0None listed on this filingEDGAR ↗
Sep 1, 2023 D/A
Chroma Medicine, Inc.
File 021-474618
$0$0$0None listed on this filingEDGAR ↗
Apr 4, 2023 D
BIOVENTRIX, INC.
File 021-477788
$0$0$1,200,000 (est.)None listed on this filingEDGAR ↗
Feb 21, 2023 D
BiVACOR Inc.
File 021-473914
$0$0$0None listed on this filingEDGAR ↗
Feb 14, 2023 D
Tioga Cardiovascular, Inc.
File 021-473481
$0$0$0None listed on this filingEDGAR ↗
Aug 22, 2022 D
Atia Vision, Inc.
File 021-456466
$0$0$0None listed on this filingEDGAR ↗
May 12, 2022 D
Adona Medical, Inc.
File 021-445373
$0$0$0None listed on this filingEDGAR ↗
Mar 10, 2022 D
Supira Medical, Inc.
File 021-436639
$0$0$0None listed on this filingEDGAR ↗
Nov 23, 2021 D
Atia Vision, Inc.
File 021-422166
$0$0$0None listed on this filingEDGAR ↗
Aug 3, 2021 D
Cormorant Private Healthcare Offshore Fund IV LP
File 021-408561
$0$0$0None listed on this filingEDGAR ↗
Aug 3, 2021 D
Cormorant Private Healthcare Fund IV LP
File 021-408560
$0$0$0None listed on this filingEDGAR ↗
Jun 16, 2021 D/A
Cormorant Private Healthcare Fund III LP
File 021-370919
$0$0$0None listed on this filingEDGAR ↗
Jun 16, 2021 D/A
Cormorant Private Healthcare Offshore Fund III LP
File 021-370920
$0$0$0None listed on this filingEDGAR ↗
Mar 1, 2021 D
BlossomHill Therapeutics, Inc.
File 021-390805
$0$0$0None listed on this filingEDGAR ↗
Sep 1, 2020 D
Adona Medical, Inc.
File 021-374655
$0$0$0None listed on this filingEDGAR ↗
May 29, 2020 D
Atea Pharmaceuticals, Inc.
File 021-367951
$500,000$0$0William Blair BrokerCheck CRD 1252 ↗EDGAR ↗
Mar 11, 2020 D
Supira Medical, Inc.
File 021-362501
$0$0$0None listed on this filingEDGAR ↗
May 9, 2019 D
Atia Vision, Inc.
File 021-339178
$0$0$0None listed on this filingEDGAR ↗
Aug 17, 2018 D
Cormorant Private Healthcare Fund II, LP
File 021-319526
$0$0$0 (est.)
Certain persons named in Item 3 or affiliate(s) thereof may receive payments deemed to be made from the proceeds of the offering, including management fees. The amount of such payments cannot be estimated at this time.
None listed on this filingEDGAR ↗
Aug 17, 2018 D
Cormorant Private Healthcare Offshore Fund II, LP
File 021-319527
$0$0$0 (est.)
Certain persons named in Item 3 or affiliate(s) thereof may receive payments deemed to be made from the proceeds of the offering, including management fees. The amount of such payments cannot be estimated at this time.
None listed on this filingEDGAR ↗
Jul 16, 2018 D
Atea Pharmaceuticals, Inc.
File 021-316941
$119,499$0$0CIM Securities, LLC BrokerCheck CRD 120852 ↗EDGAR ↗
Aug 17, 2017 D
Apellis Pharmaceuticals, Inc.
File 021-293019
$0$0$0None listed on this filingEDGAR ↗
Aug 3, 2017 D
Kezar Life Sciences, Inc.
File 021-292025
$0$0$0None listed on this filingEDGAR ↗
May 25, 2017 D
TP Therapeutics, Inc.
File 021-287476
$0$0$0None listed on this filingEDGAR ↗
Mar 21, 2016 D
TP Therapeutics, Inc.
File 021-259624
$0$0$0
The persons named in Item 3 may receive payments deemed to be made from the proceeds of the offering, including salary. The amount of such salaries cannot be estimated at this time.
None listed on this filingEDGAR ↗
Feb 8, 2016 D
Apellis Pharmaceuticals, Inc.
File 021-256958
$0$0$0None listed on this filingEDGAR ↗
Feb 1, 2016 D
Cormorant Private Healthcare Offshore Fund I, LP
File 021-256423
$0$0$0 (est.)
Certain persons named in Item 3 or affiliate(s) thereof may receive payments deemed to be made from the proceeds of the offering, including management fees. The amount of such payments cannot be estimated at this time.
None listed on this filingEDGAR ↗
Jan 15, 2016 D
CORMORANT PRIVATE HEALTHCARE FUND I, LP
File 021-255355
$0$0$0 (est.)
Certain persons named in Item 3 or affiliate(s) thereof may receive payments deemed to be made from the proceeds of the offering, including management fees. The amount of such payments cannot be estimated at this time.
None listed on this filingEDGAR ↗
Jan 11, 2016 D
C4 Therapeutics, Inc.
File 021-254901
$0$0$0None listed on this filingEDGAR ↗
Jan 6, 2016 D
Apellis Pharmaceuticals, Inc.
File 021-254589
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 30

Every issuer that named Bihua Chen on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

CP
Pooled Investment Fund · group: Cormorant

Cormorant Private Healthcare Offshore Fund VI, LP

Boston, MA · Nov 25, 2025 → Jun 25, 2026 · 2 filings
  • Jun 25, 2026 · D/A · $24,450,000 sold of $24,450,000 · 12 investors · min. $5,000,000 · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer) EDGAR ↗
  • Nov 25, 2025 · D · $13,600,000 sold of $400,000,000 · 6 investors · min. $5,000,000 · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer) EDGAR ↗

Raised $24.4M from 12 investors (100% of the $24.4M target) as of the latest filing. Bihua is listed as executive officer, promoter on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Pooled Investment Fund · group: Cormorant

Cormorant Private Healthcare Fund VI, LP

Boston, MA · Nov 25, 2025 → Jun 25, 2026 · 2 filings
  • Jun 25, 2026 · D/A · $175,550,000 sold of $175,550,000 · 56 investors · min. $5,000,000 · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer) EDGAR ↗
  • Nov 25, 2025 · D · $75,200,000 sold of $400,000,000 · 20 investors · min. $5,000,000 · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer) EDGAR ↗

Raised $175.6M from 56 investors (100% of the $175.6M target) as of the latest filing. Bihua is listed as executive officer, promoter on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CG
Pooled Investment Fund · group: Cormorant

Cormorant Global Healthcare Offshore Fund, Ltd.

Boston, MA · May 15, 2013 → Mar 3, 2026 · 13 filings
  • Mar 3, 2026 · D/A · $589,182,000 sold of Indefinite · 52 investors · min. $250,000 · role: Executive Officer (Managing Member of the General Partner of the Investment Manager of the Issuer.) EDGAR ↗
  • Mar 4, 2025 · D/A · $587,882,000 sold of Indefinite · 52 investors · min. $250,000 · role: Executive Officer (Managing Member of the General Partner of the Investment Manager of the Issuer.) EDGAR ↗
  • Mar 5, 2024 · D/A · $582,382,000 sold of Indefinite · 51 investors · min. $250,000 · role: Executive Officer (Managing Member of the General Partner of the Investment Manager of the Issuer.) EDGAR ↗
  • Mar 6, 2023 · D/A · $581,982,000 sold of Indefinite · 51 investors · min. $250,000 · role: Executive Officer (Managing Member of the General Partner of the Investment Manager of the Issuer.) EDGAR ↗
  • Mar 14, 2022 · D/A · $581,982,000 sold of Indefinite · 51 investors · min. $250,000 · role: Executive Officer (Managing Member of the General Partner of the Investment Manager of the Issuer.) EDGAR ↗
  • Feb 17, 2021 · D/A · $564,232,000 sold of Indefinite · 47 investors · min. $250,000 · role: Executive Officer, Director (Managing Member of the General Partner of the Investment Manager and Director of the Issuer.) EDGAR ↗
  • Feb 14, 2020 · D/A · $496,432,000 sold of Indefinite · 42 investors · min. $250,000 · role: Executive Officer, Director (Managing Member of the General Partner of the Investment Manager and Director of the Issuer.) EDGAR ↗
  • Feb 15, 2019 · D/A · $393,232,000 sold of Indefinite · 34 investors · min. $250,000 · role: Executive Officer, Director (Managing Member of the General Partner of the Investment Manager and Director of the Issuer.) EDGAR ↗
  • Feb 16, 2018 · D/A · $370,582,000 sold of Indefinite · 28 investors · min. $250,000 · role: Executive Officer, Director (Managing Member of Investment Manager and Director of the Issuer.) EDGAR ↗
  • Feb 16, 2017 · D/A · $338,782,000 sold of Indefinite · 28 investors · min. $250,000 · role: Executive Officer, Director (Managing Member of Investment Manager and Director of the Issuer.) EDGAR ↗
  • Feb 2, 2017 · D/A · $338,782,000 sold of Indefinite · 26 investors · min. $250,000 · role: Executive Officer, Director (Managing Member of Investment Manager and Director of the Issuer.) EDGAR ↗
  • Jan 21, 2016 · D/A · $317,632,000 sold of Indefinite · 22 investors · min. $250,000 · role: Executive Officer, Director (Managing Member of Investment Manager and Director of the Issuer.) EDGAR ↗
  • May 15, 2013 · D · $54,700,000 sold of Indefinite · 5 investors · min. $1,000,000 · role: Executive Officer, Director (Managing Member of Investment Manager and Director of the Issuer.) EDGAR ↗

Raised $589.2M from 52 investors as of the latest filing. Bihua is listed as executive officer, director on 13 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CG
Pooled Investment Fund · group: Cormorant

Cormorant Global Healthcare Fund, LP

Boston, MA · May 15, 2013 → Mar 3, 2026 · 14 filings
  • Mar 3, 2026 · D/A · $637,006,417 sold of Indefinite · 118 investors · min. $150,000 · role: Executive Officer (Managing Member of the General Partner of the Issuer and the Investment Manager of the Issuer.) EDGAR ↗
  • Mar 4, 2025 · D/A · $631,806,417 sold of Indefinite · 116 investors · min. $150,000 · role: Executive Officer (Managing Member of the General Partner of the Issuer and the Investment Manager of the Issuer.) EDGAR ↗
  • Mar 5, 2024 · D/A · $623,706,417 sold of Indefinite · 113 investors · min. $150,000 · role: Executive Officer (Managing Member of the General Partner of the Issuer and the Investment Manager of the Issuer.) EDGAR ↗
  • Mar 6, 2023 · D/A · $621,306,417 sold of Indefinite · 110 investors · min. $150,000 · role: Executive Officer (Managing Member of the General Partner of the Issuer and the Investment Manager of the Issuer.) EDGAR ↗
  • Mar 14, 2022 · D/A · $621,156,417 sold of Indefinite · 109 investors · min. $150,000 · role: Executive Officer (Managing Member of the General Partner of the Issuer and the Investment Manager of the Issuer.) EDGAR ↗
  • Feb 17, 2021 · D/A · $549,756,826 sold of Indefinite · 99 investors · min. $150,000 · role: Executive Officer (Managing Member of the General Partner of the Issuer and the Investment Manager of the Issuer.) EDGAR ↗
  • Feb 14, 2020 · D/A · $503,534,963 sold of Indefinite · 92 investors · min. $150,000 · role: Executive Officer (Managing Member of the General Partner of the Issuer and the Investment Manager of the Issuer.) EDGAR ↗
  • Feb 15, 2019 · D/A · $478,484,963 sold of Indefinite · 84 investors · min. $150,000 · role: Executive Officer (Managing Member of the General Partner of the Issuer and the Investment Manager of the Issuer.) EDGAR ↗
  • Feb 16, 2018 · D/A · $429,484,963 sold of Indefinite · 75 investors · min. $150,000 · role: Executive Officer (Managing Member of the General Partner and Investment Manager of the Issuer.) EDGAR ↗
  • Feb 16, 2017 · D/A · $392,278,810 sold of Indefinite · 74 investors · min. $150,000 · role: Executive Officer (Managing Member of the General Partner and Investment Manager of the Issuer.) EDGAR ↗
  • Feb 1, 2017 · D/A · $300,769,206 sold of Indefinite · 74 investors · min. $150,000 · role: Executive Officer (Managing Member of the General Partner and Investment Manager of the Issuer.) EDGAR ↗
  • Jan 26, 2016 · D/A · $272,200,000 sold of Indefinite · 68 investors · min. $150,000 · role: Executive Officer (Managing Member of the General Partner and Investment Manager of the Issuer.) EDGAR ↗
  • Jan 21, 2016 · D/A · $272,200,000 sold of Indefinite · 68 investors · min. $150,000 · role: Executive Officer (Managing Member of the General Partner and Investment Manager of the Issuer.) EDGAR ↗
  • May 15, 2013 · D · $84,450,000 sold of Indefinite · 20 investors · min. $1,000,000 · role: Executive Officer (Managing Member of the General Partner and Investment Manager of the Issuer.) EDGAR ↗

Raised $637M from 118 investors as of the latest filing. Bihua is listed as executive officer on 14 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

BT
Pharmaceuticals

BlossomHill Therapeutics, Inc.

San Diego, CA · Mar 1, 2021 → Dec 10, 2025 · 3 filings
  • Dec 10, 2025 · D · $84,152,909 sold of $84,152,909 · 47 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 2, 2024 · D · $88,649,917 sold of $99,999,997 · 44 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 1, 2021 · D · $70,999,993 sold of $70,999,993 · 27 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $88.6M from 47 investors (100% of the $84.2M target) as of the latest filing. Bihua is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AM
Other Health Care · group: Supira

Akura Medical, Inc.

Campbell, CA · Dec 3, 2025
  • Dec 3, 2025 · D · $51,449,999 sold of $71,999,999 · 20 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $51.4M from 59 investors (71% of the $72M target) as of the latest filing. Bihua is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TC
Other Health Care · group: Supira

Tioga Cardiovascular, Inc.

Campbell, CA · Feb 14, 2023 → Sep 16, 2025 · 2 filings
  • Sep 16, 2025 · D · $22,897,352 sold of $22,897,352 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 14, 2023 · D · $16,044,989 sold of $30,594,998 · 15 investors · min. $1 · role: Director EDGAR ↗

Raised $22.9M from 24 investors (100% of the $22.9M target) as of the latest filing. Bihua is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SM
Other Health Care · group: Supira

Supira Medical, Inc.

Campbell, CA · Mar 11, 2020 → Apr 3, 2025 · 4 filings
  • Apr 3, 2025 · D · $119,999,984 sold of $119,999,984 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 1, 2023 · D · $21,086,842 sold of $39,999,985 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 10, 2022 · D · $29,999,980 sold of $30,000,000 · 31 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 11, 2020 · D · $35,099,991 sold of $35,099,991 · 31 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $120M from 31 investors (100% of the $120M target) as of the latest filing. Bihua is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Pooled Investment Fund · group: Cormorant

Cormorant Private Healthcare Fund V LP

Boston, MA · Aug 9, 2023 → Aug 8, 2024 · 2 filings
  • Aug 8, 2024 · D/A · $318,000,000 sold of $318,000,000 · 56 investors · min. $5,000,000 · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer) EDGAR ↗
  • Aug 9, 2023 · D · $273,775,000 sold of $400,000,000 · 29 investors · min. $5,000,000 · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer) EDGAR ↗

Raised $318M from 56 investors (100% of the $318M target) as of the latest filing. Bihua is listed as executive officer, promoter on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Pooled Investment Fund · group: Cormorant

Cormorant Private Healthcare Offshore Fund V LP

Boston, MA · Aug 9, 2023 → Aug 8, 2024 · 2 filings
  • Aug 8, 2024 · D/A · $119,000,000 sold of $119,000,000 · 20 investors · min. $5,000,000 · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer) EDGAR ↗
  • Aug 9, 2023 · D · $55,500,000 sold of $400,000,000 · 5 investors · min. $5,000,000 · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer) EDGAR ↗

Raised $119M from 20 investors (100% of the $119M target) as of the latest filing. Bihua is listed as executive officer, promoter on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

B
Other Technology

BiVACOR Inc.

Huntington Beach, CA · Feb 21, 2023 → Aug 6, 2024 · 2 filings
  • Aug 6, 2024 · D · $9,000,003 sold of $28,000,001 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 21, 2023 · D · $15,000,000 sold of $36,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $15M from 4 investors (54% of the $28M target) as of the latest filing. Bihua is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Technology / 506(b) (17,390 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AM
Other Health Care

Adona Medical, Inc.

Los Gatos, CA · Sep 1, 2020 → Jul 11, 2024 · 3 filings
  • Jul 11, 2024 · D · $13,369,997 sold of $35,019,999 · 23 investors · min. $1 · role: Director EDGAR ↗
  • May 12, 2022 · D · $20,199,995 sold of $39,999,999 · 31 investors · min. $1 · role: Director EDGAR ↗
  • Sep 1, 2020 · D · $20,481,983 sold of $24,840,000 · 45 investors · min. $1 · role: Director EDGAR ↗

Raised $20.5M from 45 investors (58% of the $35M target) as of the latest filing. Bihua is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

GB
Biotechnology

Graviton BioScience Corp

New York, NY · Dec 4, 2023 → Feb 14, 2024 · 3 filings
  • Feb 14, 2024 · D · $24,999,996 sold of $24,999,996 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 4, 2023 · D · $39,819,496 sold of $50,000,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 4, 2023 · D · $24,999,998 sold of $24,999,998 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $39.8M from 11 investors (100% of the $25M target) as of the latest filing. Bihua is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CM
Biotechnology

Chroma Medicine, Inc.

Boston, MA · Mar 1, 2023 → Sep 1, 2023 · 2 filings
  • Sep 1, 2023 · D/A · $135,000,000 sold of $135,000,000 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 1, 2023 · D · $135,000,000 sold of $135,000,000 · 21 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $135M from 21 investors (100% of the $135M target) as of the latest filing. Bihua is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

B
Other

BIOVENTRIX, INC.

Mansfield, MA · Apr 4, 2023
  • Apr 4, 2023 · D · $12,650,000 sold of $15,650,000 · 12 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $40.8M from 195 investors (100% of the $15.7M target) as of the latest filing. Bihua is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AV
Biotechnology

Atia Vision, Inc.

Campbell, CA · May 9, 2019 → Aug 22, 2022 · 3 filings
  • Aug 22, 2022 · D · $28,650,000 sold of $28,650,000 · 10 investors · min. $15,000 · role: Director EDGAR ↗
  • Nov 23, 2021 · D · $5,435,000 sold of $6,500,000 · 12 investors · min. $31,000 · role: Director EDGAR ↗
  • May 9, 2019 · D · $11,637,507 sold of $20,000,007 · 21 investors · min. $24,999 · role: Director EDGAR ↗

Raised $28.6M from 21 investors (100% of the $28.6M target) as of the latest filing. Bihua is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Pooled Investment Fund · group: Cormorant

Cormorant Private Healthcare Offshore Fund IV LP

Boston, MA · Aug 3, 2021
  • Aug 3, 2021 · D · $69,200,000 sold of $400,000,000 · 7 investors · min. $5,000,000 · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer) EDGAR ↗

Raised $69.2M from 7 investors (17% of the $400M target) as of the latest filing. Bihua is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Pooled Investment Fund · group: Cormorant

Cormorant Private Healthcare Fund IV LP

Boston, MA · Aug 3, 2021
  • Aug 3, 2021 · D · $252,686,000 sold of $400,000,000 · 34 investors · min. No minimum reported · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer) EDGAR ↗

Raised $252.7M from 34 investors (63% of the $400M target) as of the latest filing. Bihua is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Pooled Investment Fund · group: Cormorant

Cormorant Private Healthcare Offshore Fund III LP

Boston, MA · Jul 14, 2020 → Jun 16, 2021 · 2 filings
  • Jun 16, 2021 · D/A · $213,650,000 sold of $419,913,000 · 38 investors · min. No minimum reported · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer.) EDGAR ↗
  • Jul 14, 2020 · D · $131,500,000 sold of $500,000,000 · 25 investors · min. No minimum reported · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer.) EDGAR ↗

Raised $213.7M from 38 investors (51% of the $419.9M target) as of the latest filing. Bihua is listed as executive officer, promoter on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Pooled Investment Fund · group: Cormorant

Cormorant Private Healthcare Fund III LP

Boston, MA · Jul 14, 2020 → Jun 16, 2021 · 2 filings
  • Jun 16, 2021 · D/A · $206,263,000 sold of $419,913,000 · 81 investors · min. No minimum reported · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer) EDGAR ↗
  • Jul 14, 2020 · D · $144,175,000 sold of $500,000,000 · 51 investors · min. No minimum reported · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer) EDGAR ↗

Raised $206.3M from 81 investors (49% of the $419.9M target) as of the latest filing. Bihua is listed as executive officer, promoter on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AP
Biotechnology

Atea Pharmaceuticals, Inc.

Boston, MA · Jul 16, 2018 → May 29, 2020 · 2 filings
  • May 29, 2020 · D · $107,499,941 sold of $214,999,608 · 37 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 16, 2018 · D · $27,599,934 sold of $27,599,934 · 38 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $107.5M from 59 investors (50% of the $215M target) as of the latest filing. Bihua is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Pooled Investment Fund · group: Cormorant

Cormorant Private Healthcare Offshore Fund II, LP

Boston, MA · Aug 17, 2018
  • Aug 17, 2018 · D · $93,200,000 sold of $350,000,000 · 14 investors · min. No minimum reported · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer.) EDGAR ↗

Raised $93.2M from 14 investors (27% of the $350M target) as of the latest filing. Bihua is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Pooled Investment Fund · group: Cormorant

Cormorant Private Healthcare Fund II, LP

Boston, MA · Aug 17, 2018
  • Aug 17, 2018 · D · $105,550,000 sold of $350,000,000 · 39 investors · min. No minimum reported · role: Executive Officer, Promoter (Ms. Chen is the founder and Managing Member of the General Partner of the Issuer and the founder and portfolio manager of the Investment Manager of the Issuer.) EDGAR ↗

Raised $105.5M from 39 investors (30% of the $350M target) as of the latest filing. Bihua is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AP
Pharmaceuticals · group: Apellis

Apellis Pharmaceuticals, Inc.

Crestwood, KY · Jan 6, 2016 → Aug 17, 2017 · 3 filings
  • Aug 17, 2017 · D · $20,033,322 sold of $60,099,974 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 8, 2016 · D · $47,135,951 sold of $47,135,951 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 6, 2016 · D · $32,135,952 sold of $32,135,952 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $47.1M from 25 investors (78% of the $60.1M target) as of the latest filing. Bihua is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

KL
Biotechnology

Kezar Life Sciences, Inc.

South San Francisco, CA · Aug 3, 2017
  • Aug 3, 2017 · D · $49,999,985 sold of $49,999,985 · 24 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $50M from 49 investors (100% of the $50M target) as of the latest filing. Bihua is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TT
Pharmaceuticals · group: Tp Therapeutics

TP Therapeutics, Inc.

San Diego, CA · May 25, 2017
  • May 25, 2017 · D · $45,000,017 sold of $45,000,017 · 13 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $80M from 16 investors (100% of the $45M target) as of the latest filing. Bihua is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TT
Pharmaceuticals · group: Tp Therapeutics

TP Therapeutics, Inc.

San Diego, CA · Mar 21, 2016
  • Mar 21, 2016 · D · $17,979,732 sold of $18,000,340 · 26 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $18M from 26 investors (100% of the $18M target) as of the latest filing. Bihua is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Pooled Investment Fund · group: Cormorant

Cormorant Private Healthcare Offshore Fund I, LP

Boston, MA · Feb 1, 2016
  • Feb 1, 2016 · D · $0 sold of $130,000,000 · 0 investors · min. $5,000,000 · role: Executive Officer, Promoter (Ms. Chen is the Managing Member of the General Partner of the Issuer and the founder of the Investment Manager of the Issuer.) EDGAR ↗

No sales reported yet as of the latest filing. Bihua is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CP
Pooled Investment Fund · group: Cormorant

CORMORANT PRIVATE HEALTHCARE FUND I, LP

Boston, MA · Jan 15, 2016
  • Jan 15, 2016 · D · $28,959,990 sold of $250,000,000 · 14 investors · min. $5,000,000 · role: Executive Officer, Promoter (Ms. Chen is the Managing Member of the General Partner of the Issuer and the founder of the Investment Manager of the Issuer.) EDGAR ↗

Raised $29M from 14 investors (12% of the $250M target) as of the latest filing. Bihua is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CT
Biotechnology

C4 Therapeutics, Inc.

Cambridge, MA · Jan 11, 2016
  • Jan 11, 2016 · D · $70,315,000 sold of $73,485,000 · 55 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $70.3M from 55 investors (96% of the $73.5M target) as of the latest filing. Bihua is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (2)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Bihua Chen — NJ, 1 issuer, Apr 5, 2023 → Apr 5, 2023 · no shared issuer
  • Bihua Chen — PA, 1 issuer, Jun 3, 2024 → Jun 3, 2024 · no shared issuer

People around Bihua 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

CA
Management entity

Cormorant Asset Management, LLC

Executive Officer, Promoter · 45 shared filings (14 issuers)

Cormorant Asset Management, LLC is on 14 issuers in total — a repeat sponsor. Their page lists every one.

CG
Management entity

Cormorant Global Healthcare GP, LLC

Executive Officer, Promoter · 14 shared filings (1 issuer)

Listed on the same filings as Bihua Chen. Their page shows their other deals.

DF
Management entity

DMS Fund Governance II Ltd

Director · 2 shared filings (1 issuer)

Listed on the same filings as Bihua Chen. Their page shows their other deals.

DF
Management entity

DMS Fund Governance I Ltd

Director · 2 shared filings (1 issuer)

Listed on the same filings as Bihua Chen. Their page shows their other deals.

CP
Management entity

Cormorant Private Healthcare GP, LLC

Executive Officer, Promoter · 2 shared filings (2 issuers)

Listed on the same filings as Bihua Chen. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jay Scollins

Executive Officer, Promoter · 23 shared filings (8 issuers) · also on 2 other issuers

Jay Scollins is on 10 issuers in total — a repeat sponsor. Their page lists every one.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Amr Salahieh

Executive Officer, Director · 13 shared filings (5 issuers) · also on 5 other issuers

Amr Salahieh is on 10 issuers in total — a repeat sponsor. Their page lists every one.

CT
No photo found yet (own website and image search run after this page is viewed)
Person

Caleb Tripp

Executive Officer, Promoter · 12 shared filings (8 issuers)

Caleb Tripp is on 8 issuers in total — a repeat sponsor. Their page lists every one.

KP
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin Phillip

Director · 11 shared filings (1 issuer) · also on 102 other issuers

Kevin Phillip is on 103 issuers in total — a repeat sponsor. Their page lists every one.

PM
No photo found yet (own website and image search run after this page is viewed)
Person

Paras Malde

Director · 11 shared filings (1 issuer) · also on 77 other issuers

Paras Malde is on 78 issuers in total — a repeat sponsor. Their page lists every one.

NO
No photo found yet (own website and image search run after this page is viewed)
Person

Neb Obradovic

Executive Officer, Director · 10 shared filings (2 issuers)

Listed on the same filings as Bihua Chen. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Casey Gordon

Director · 7 shared filings (2 issuers) · also on 3 other issuers

Casey Gordon is on 5 issuers in total — a repeat sponsor. Their page lists every one.

GL
No photo found yet (own website and image search run after this page is viewed)
Person

George Lee

Director · 5 shared filings (3 issuers) · also on 6 other issuers

George Lee is on 9 issuers in total — a repeat sponsor. Their page lists every one.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Mariam Maghribi

Director, Executive Officer · 5 shared filings (3 issuers) · also on 3 other issuers

Mariam Maghribi is on 6 issuers in total — a repeat sponsor. Their page lists every one.

GK
No photo found yet (own website and image search run after this page is viewed)
Person

Gautam Kainth

Director · 5 shared filings (3 issuers)

Listed on the same filings as Bihua Chen. Their page shows their other deals.

YL
No photo found yet (own website and image search run after this page is viewed)
Person

Yishan Li

Executive Officer, Director · 4 shared filings (3 issuers) · also on 1 other issuer

Listed on the same filings as Bihua Chen. Their page shows their other deals.

GC
No photo found yet (own website and image search run after this page is viewed)
Person

Gerald Chan

Director · 4 shared filings (2 issuers) · also on 9 other issuers

Gerald Chan is on 11 issuers in total — a repeat sponsor. Their page lists every one.

NS
No photo found yet (own website and image search run after this page is viewed)
Person

Nitin Salunke

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Bihua Chen. Their page shows their other deals.

JC
No photo found yet (own website and image search run after this page is viewed)
Person

Jingrong Jean Cui

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Bihua Chen. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Carl L. Gordon

Director · 3 shared filings (1 issuer) · also on 61 other issuers

Carl L. Gordon is on 62 issuers in total — a repeat sponsor. Their page lists every one.

SD
No photo found yet (own website and image search run after this page is viewed)
Person

Sinclair Dunlop

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Bihua Chen. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Stephanie O'Brien

Director · 3 shared filings (1 issuer) · also on 7 other issuers

Stephanie O'Brien is on 8 issuers in total — a repeat sponsor. Their page lists every one.

CF
No photo found yet (own website and image search run after this page is viewed)
Person

Cedric Francois

Executive Officer, Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Bihua Chen. Their page shows their other deals.

PD
No photo found yet (own website and image search run after this page is viewed)
Person

Pascal Deschatelets

Executive Officer · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Bihua Chen. Their page shows their other deals.

SP
No photo found yet (own website and image search run after this page is viewed)
Person

Stelios Papadopoulos

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Bihua Chen. Their page shows their other deals.

SW
No photo found yet (own website and image search run after this page is viewed)
Person

Samuel D Waksal

Executive Officer, Director, Promoter · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Bihua Chen. Their page shows their other deals.

BF
No photo found yet (own website and image search run after this page is viewed)
Person

Brian Fahey

Executive Officer, Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Bihua Chen. Their page shows their other deals.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Alec Machiels

Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Bihua Chen. Their page shows their other deals.

DW
No photo found yet (own website and image search run after this page is viewed)
Person

David Watson

Executive Officer · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Bihua Chen. Their page shows their other deals.

DG
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel Geffken

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Bihua Chen. Their page shows their other deals.

NP
No photo found yet (own website and image search run after this page is viewed)
Person

Nicole Perry

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Bihua Chen. Their page shows their other deals.

CA
No photo found yet (own website and image search run after this page is viewed)
Person

Claudio Argento

Director · 3 shared filings (1 issuer)

Listed on the same filings as Bihua Chen. Their page shows their other deals.

RN
No photo found yet (own website and image search run after this page is viewed)
Person

Ran Nussbaum

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Bihua Chen. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

David MacMillan

Director · 3 shared filings (1 issuer)

Listed on the same filings as Bihua Chen. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

James Boylan

Director · 3 shared filings (1 issuer)

Listed on the same filings as Bihua Chen. Their page shows their other deals.

The team behind the deals

C
Sponsor group

Cormorant

14 issuers · 45 filings · $2.83B reported sold · 2013–2026

One team, 14 deal companies. Bihua Chen is listed on 14 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Bihua Chen.

S
Sponsor group

Supira

4 issuers · 14 filings · $219.8M reported sold · 2017–2025

One team, 4 deal companies. Bihua Chen is listed on 3 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Bihua Chen.

TT
Sponsor group

Tp Therapeutics

2 issuers · 4 filings · $98M reported sold · 2014–2018

One team, 2 deal companies. Bihua Chen is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Bihua Chen.

A
Sponsor group

Apellis

3 issuers · 20 filings · $24.9M reported sold · 2010–2025

One team, 3 deal companies. Bihua Chen is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Bihua Chen.

Same business address

32 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

A person is never an adviser firm. 14 of the 30 issuers this person is listed on match a Form ADV adviser (searched 24,962 advisers as of Oct 2, 2026): Cormorant Private Healthcare Offshore Fund VI, LP, Cormorant Private Healthcare Fund VI, LP, Cormorant Global Healthcare Offshore Fund, Ltd., Cormorant Global Healthcare Fund, LP, Cormorant Private Healthcare Offshore Fund V LP, Cormorant Private Healthcare Fund V LP, Cormorant Private Healthcare Offshore Fund IV LP, Cormorant Private Healthcare Fund IV LP, Cormorant Private Healthcare Offshore Fund III LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Offshore Fund II, LP, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare Offshore Fund I, LP, CORMORANT PRIVATE HEALTHCARE FUND I, LP.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Bihua Chen by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 30 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Bihua Chen is listed on: none on file. No website or social profile named in Cormorant Private Healthcare Fund V LP's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #92,828 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Boston, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗Massachusetts MassCourts ↗Kentucky state courts — find the court ↗Texas re:SearchTX court records ↗New York WebCivil Supreme ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗Massachusetts Secretary of State business search ↗Kentucky Secretary of State business search ↗Texas Secretary of State business search ↗New York Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Bihua Chen appears on a new Form D, or when a court case or SEC action is matched to them. See plans →